PositiveID Corporation (OTCQB: PSID) is an emerging growth company that develops biological detection and diagnostic systems for America's homeland defense and the global healthcare market. PositiveID specializes in microfluidic systems for the automated preparation and performance of biological assays in order to detect biological threats and outbreaks whether airborne, in a healthcare setting, or at the point of need.
Nov 14, 2017
Oct 24, 2017
PositiveID's ExcitePCR Subsidiary Publishes White Paper: PCR Unchained: The Coming Revolution in Field-Based Pathogen Detection